Oncology (Philanthropy)

IM

Ishtiaq Mawla

Associate Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Ishtiaq Mawla is an associate director on the Science Philanthropy Accelerator for Research and Collaboration team at the Milken Institute Strategic Philanthropy.
Image
An image of a smiling light-skinned female-presenting person named Elizabeth Burke with light hair wearing a black shirt against a nature-ish background

Elizabeth Burke, PhD

Associate Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Elizabeth Burke, PhD, is an associate director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. Her expertise lies in rare disease research, including neurodevelopmental and neurodegenerative disorders, strategic planning, project management, and promoting collaboration between clinical and scientific teams.

Oncology

Body

"You have cancer." These words are among the most difficult anyone will ever have to hear. Yet of the 100 or so cancers known to science, there are cures for only 30 percent. Many, while treatable, have different prognoses, and treatments are difficult to endure for the patient, and for the entire family.

As many know, cancer is a leading cause of death globally, accounting for 10 million deaths globally in 2020 alone. Building on strategy-building work with the Melanoma Research Alliance and the Prostate Cancer Foundation, Milken Institute Philanthropy works with partners to identify promising but under-resourced approaches for cancer treatment.

We lead donors through the cancer research ecosystem, bringing experts from other sectors to the table to unlock potential that will lead to better treatments—and eventually a cure—for a range of cancers. 

Level
Practice Area
Children type
Programs
Image
A smiling light-skinned female named Cara Altimus with shoulder length dark brown hair wearing a vibrant blue shirt and red necklace, standing with her arms crossed against an ambiguous outdoor background.

Cara Altimus, PhD

Managing Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Cara Altimus, PhD is a managing director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy, leading the science and health innovation portfolio. A PhD neuroscientist, Altimus advises individual philanthropists and foundations on the state of research for various areas including neurodegenerative disease and mental health, identifying opportunities where their capital can make the biggest impact.
Image
An image of a female-presenting person named Nadia Penrod. She has medium length brown hair and white skin. She is smiling at the camera and wearing a black jacket with a tan sweater.

Nadia Penrod, PhD

Senior Associate, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Nadia Penrod,PhD, is a senior associate on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. In this role, she leverages her expertise as an interdisciplinary scientist in biomedicine and informatics to identify high-impact opportunities for philanthropic investment that promote science for the public good and have the potential to transform health.
Image
Light-skinned female-presenting person named Caitlyn Barrett with light hair in a yellow jacket and black shirt with gray gradient background

Caitlyn Barrett, PhD

Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic Philanthropy
Caitlyn Barrett, PhD, is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. Her scientific expertise in cancer biology and neurodegeneration in addition to her experience in grant and program management, stakeholder engagement, and program analysis are brought to bear as she partners with philanthropists to maximize their impact on the biomedical ecosystem.